Recombinant Mouse P2yr13 Protein ，His

P2yr13 is a member of the P2Y family of purinergic receptors, which are G-protein-coupled receptors (GPCRs) that play crucial roles in various physiological processes by responding to extracellular nucleotides, such as ATP and ADP. These receptors are involved in numerous signaling pathways that regulate cardiovascular functions, immune responses, and neurotransmission. Research on P2yr13 specifically has garnered increasing interest due to its potential implications in various diseases, including inflammation, cancer, and cardiovascular disorders. Understanding the structural and functional characteristics of P2yr13 is essential for elucidating its role in these pathological conditions. Recombinant expression of P2yr13 allows for advanced studies on its pharmacology and signaling mechanisms, facilitating the identification of potential therapeutic targets. Current studies focus on characterizing the receptor's ligand-binding properties, its activation mechanisms, and downstream signaling pathways. The exploration of P2yr13 also aims to identify small molecule modulators that can selectively target this receptor, providing insights into developing novel treatments for diseases associated with purinergic signaling dysregulation. As research progresses, the recombinant protein's utility in drug discovery and therapeutic applications will significantly enhance our understanding of purinergic signaling mechanisms and their contributions to health and disease.